GSK3145095
CAS: 1622849-43-7
Ref. 3D-XPC84943
| 1mg | Nachfragen | |
| 5mg | Nachfragen | |
| 10mg | Nachfragen | |
| 25mg | Nachfragen | |
| 50mg | Nachfragen |
Produktinformation
GSK3145095 is a small molecule that has been shown to be active in the treatment of inflammatory diseases and cancer. GSK3145095 is a potent inhibitor of NF-κB, which is an inflammatory mediator and regulator of immune responses. This drug has synergistic effects with other drugs, such as methotrexate, which are used in the treatment of cancer. GSK3145095 shows promise as a potential therapeutic agent for various types of cancers. The drug has been shown to inhibit proliferation and induce apoptosis in cancer cells by targeting the microenvironment of these cells (e.g., tumor blood vessels). GSK3145095 also potently inhibits a broad range of infectious disease agents, including Mycobacterium tuberculosis and human immunodeficiency virus type 1 (HIV-1). Clinical trials are currently underway for this compound to determine its efficacy for the treatment of cancer.
Chemische Eigenschaften
Technische Anfrage zu: 3D-XPC84943 GSK3145095
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
